{"id":903,"date":"2026-07-28T09:34:00","date_gmt":"2026-07-28T00:34:00","guid":{"rendered":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-07-28-who-hiv-hepatitis-sti-midterm-en\/"},"modified":"2026-07-28T09:34:00","modified_gmt":"2026-07-28T00:34:00","slug":"2026-07-28-who-hiv-hepatitis-sti-midterm-en","status":"publish","type":"briefing","link":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-07-28-who-hiv-hepatitis-sti-midterm-en\/","title":{"rendered":"HIV deaths down 57%, hepatitis B deaths up 17%: WHO finds a split global picture"},"content":{"rendered":"

2026-07-28 09:34 KST<\/strong><\/p>\n

WHO has released the first global mid-term assessment of its 2022\u20132030 strategies for HIV, viral hepatitis and sexually transmitted infections.<\/p>\n

HIV has made substantial gains, but hepatitis B mortality has moved in the opposite direction and none of the three responses is on track for 2030.<\/p>\n

The two headline percentages use different baselines<\/h2>\n

HIV-related deaths reached 570,000 in 2025, 57% below 2010. Hepatitis B-related deaths reached about 1.1 million in 2024, 17% above 2015.<\/p>\n

New HIV infections fell 42% from 2010 to 1.2 million in 2025. Hepatitis C-related deaths fell 12% from 2015 to 240,000 in 2024. The latest years and baselines differ, so the percentage sizes are not a direct like-for-like comparison.<\/p>\n

HIV progress still falls short of the target<\/h2>\n

About 32 million people were receiving HIV treatment by the end of 2025, while roughly 9 million lacked access to lifesaving therapy. The 2030 goal is a 90% reduction in both new infections and deaths from 2010.<\/p>\n

Donor cuts have already affected prevention, testing, treatment initiation and laboratory capacity. In a WHO survey, 47 of 107 responding countries reported some HIV service disruption in 2025.<\/p>\n

\"Produced
Produced explanatory image: it represents integrated global health services and is not a real WHO meeting or a scene involving identified patients.<\/figcaption><\/figure>\n

Hepatitis B deaths rose despite available tools<\/h2>\n

Hepatitis B and C together caused an estimated 1.3 million deaths in 2024. Effective antivirals exist, but diagnosis and treatment coverage remain low; hepatitis B birth-dose vaccination coverage in the African Region was only 17%.<\/p>\n

Twenty of the region\u2019s 47 countries had not implemented the birth dose. The central problem is the gap between available prevention and real access.<\/p>\n

STIs are worsening, but the total is uncertain<\/h2>\n

STI rates are rising in several countries and communities, while resistance to gonorrhoea antibiotics is growing. Yet major infections are often not notifiable and standardized reporting remains absent.<\/p>\n

The report therefore treats weak surveillance, diagnostics, financing and health information systems as part of the emergency, not just a technical footnote.<\/p>\n

Integration is the priority for the next five years<\/h2>\n

WHO calls for HIV, hepatitis and STI services to be integrated with primary care, tuberculosis, maternal and child health, and sexual and reproductive health.<\/p>\n

This is a global assessment as checked on July 28, 2026. Country-level treatment, vaccination and testing data, followed by the 2028 progress report, will show whether the gaps actually narrow.<\/p>\n

Official Primary Sources<\/h2>\n

WHO: 2026 mid-term progress report, 122 pages and data tables<\/a><\/p>\n

WHO: official release with HIV, hepatitis and STI headline figures<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

WHO\u2019s 2026 global mid-term assessment finds HIV-related deaths fell 57% from 2010, while hepatitis B-related deaths rose 17% from 2015. All three disease responses remain off track for 2030, and STI surveillance is too weak to measure the full trend.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":[],"class_list":["post-903","briefing","type-briefing","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing\/903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing"}],"about":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/types\/briefing"}],"wp:attachment":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/media?parent=903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}